Novo Nordisk is a Danish pharmaceutical company. Its focus is diabetes and weight-loss drugs such as insulins, Ozempic and Wegovy, plus treatments for rare blood and hormone disorders. ADRs are traded in the US. As of Oct 11, 2026
As of Oct 11, 2026Fact sheet (from the annual report)Pharmaceutical manufacturers · Bagsvaerd Denmark, Denmarkfull fact sheet
According to the company, Novo Nordisk is a global healthcare company based in Denmark that makes and sells medicines. The group reports in the segments obesity and diabetes, and rare diseases. Its range includes active ingredients that activate the GLP-1 receptor for treating obesity and diabetes as well as modern and human insulins for diabetes. In rare diseases, the group mainly offers growth hormones and treatments for hemophilia. For the manufacture, development, marketing and reimbursement of its products, the group depends on government approvals.
Our own calculation from the exchange’s daily candles, as of Oct 26, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Fundamentals · Analysis method
Growth, margin and debt compared with the sector – in detail in the fundamental analysis further down. The chart shows the candles without a buy zone.
Growth: greenMargin: greenDebt: gray
Load chart from TradingView
This transfers data (including your IP address) to TradingView, also to the USA. More in the Privacy policy.
With a free account: save the buy zone shown for yourself (stop and targets from Watcher). It stays visible even if the zone changes later. Log in
· Sign up
Fundamental analysis
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
Novo Nordisk (ADR) · amounts in DKK
Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of Feb 4, 2026.
In short
Light green: Revenue grew over 5 years (+19.5% per year).
Light green: Net income (total) grew over 5 years (+19.4% per year); per share +5.0% per year.
Light green: Net margin 33.1%.
Light green: Profit in each of the last 10 fiscal years.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in DKK
0100B200B300B400B
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 111.8B DKK · Net income 37.9B DKK · Net margin 33.9%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 111.7B DKK · Net income 38.1B DKK · Net margin 34.1%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 111.8B DKK · Net income 38.6B DKK · Net margin 34.5%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 122.0B DKK · Net income 39.0B DKK · Net margin 31.9%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 126.9B DKK · Net income 42.1B DKK · Net margin 33.2%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 140.8B DKK · Net income 47.8B DKK · Net margin 33.9%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 177.0B DKK · Net income 55.5B DKK · Net margin 31.4%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 232.3B DKK · Net income 83.7B DKK · Net margin 36.0%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 290.4B DKK · Net income 101.0B DKK · Net margin 34.8%
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 309.1B DKK · Net income 102.4B DKK · Net margin 33.1%
Margin
34%34%35%32%33%34%31%36%35%33%
No quarterly figures reported (companies filing a 20-F annual report usually report only once a year).
Earnings per shareDKK per share
0102030
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Earnings per share 14.96 DKK
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Earnings per share 15.39 DKK
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Earnings per share 15.93 DKK
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Earnings per share 16.38 DKK
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Earnings per share 18.01 DKK
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Earnings per share 20.74 DKK
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Earnings per share 24.44 DKK
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Earnings per share 18.62 DKK
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Earnings per share 22.63 DKK
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Earnings per share 23.03 DKK
No quarterly figures reported (companies filing a 20-F annual report usually report only once a year).
No reported values for “Dividend per share” in this interval.
No quarterly figures reported (companies filing a 20-F annual report usually report only once a year).
Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 309.1B DKK · Net income 102.4B DKK · Net margin 33.1%
Key figures with traffic lights
Each light follows a simple, disclosed rule. This symbol has no sector assignment – lights with a sector comparison stay gray or use only the basic rule.
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light green: growing
+19.5%per year, last 5 years
What does this mean? Revenue: over 5 years it grew by 19.5% per year on average. Comparable values for a sector comparison are missing.
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light green: growing
+19.4%per year, last 5 years
per share: +5.0% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it grew by 19.4% per year on average. Comparable values for a sector comparison are missing.
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 DKK in revenue, 33.14 DKK remained as profit. Comparable values for a sector comparison are missing.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light gray: no comparison
0.67latest balance sheet
What does this mean? For every 1 DKK of equity there is 0.67 DKK of financial debt. Without a sector comparison this is hard to put into context.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light gray: none found
–Dividend / earnings per share
What does this mean? The loaded SEC filings of the last two fiscal years contain no dividend per share. Either the company pays none, or it reports it under a different tag.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light green: profit every year
10 of 10fiscal years with a profit
What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
309.1B DKK
Revenue vs. prior year
+6.4%
Net income (FY)
102.4B DKK
Net income vs. prior year
+1.4%
EPS (FY)
23.03 DKK
13F funds with a position
2 of 9
Funds vs. prior quarter
+1
Shares held vs. prior quarter
−52.0%
Fiscal year to Dec 31, 2025 · 20-F filed Feb 4, 2026 · Balance sheet Dec 31, 2025 (filed Feb 4, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).13F: reporting date Jun 30, 2026, 9 tracked funds have filed (latest Aug 14, 2026), filed with up to 45 days of delay. Stock positions only; comparison with Mar 31, 2026 only across funds that filed for both quarters.
All figures as a table
Fiscal years (amounts in DKK, per share in DKK)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2025
Dec 31, 2025
309.1B
102.4B
33.1%
23.03
–
–
2024
Dec 31, 2024
290.4B
101.0B
34.8%
22.63
–
–
2023
Dec 31, 2023
232.3B
83.7B
36.0%
18.62
–
–
2022
Dec 31, 2022
177.0B
55.5B
31.4%
24.44
–
–
2021
Dec 31, 2021
140.8B
47.8B
33.9%
20.74
–
–
2020
Dec 31, 2020
126.9B
42.1B
33.2%
18.01
–
–
2019
Dec 31, 2019
122.0B
39.0B
31.9%
16.38
–
–
2018
Dec 31, 2018
111.8B
38.6B
34.5%
15.93
–
–
2017
Dec 31, 2017
111.7B
38.1B
34.1%
15.39
–
–
2016
Dec 31, 2016
111.8B
37.9B
33.9%
14.96
–
–
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
In the last 12 months, insiders of this stock have not acquired or disposed of shares on the market (SEC Form 4).
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Trend score -75
Price vs. EMA 50-15
Price vs. EMA 200-15
EMA 50 vs. EMA 200-20
ADX (trend strength)+0
Highs and lows-10
Relative strength-15
Volatility and trend strength
ADX 14 (trend strength)20.5
Rel. strength 60 d−18.3%
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.